SHARON, Pa., Oct. 18 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (Pink Sheets: NNLX), a nanobiotechnology company moving rapidly towards the commercialization of its proprietary technologies for hydrogen generation systems, announced today that it has signed an agreement to install a NanoLogix hydrogen generation system using Welch Food's waste organic matter. The NanoLogix methodology for hydrogen production is being developed for the limitless production of hydrogen from organic containing waste waters. Once successfully accomplished, this has the potentiality for solving the world energy crisis through the limitless production of hydrogen from any waste organic materials, such as sewer water, ground up garbage, etc. NanoLogix has assembled a distinguished team of scientists and university professors to work on this exciting project. The NanoLogix reactor will utilize multiple proprietary methodologies for synergistically creating a hydrogen bioreactor. The hydrogen production method will utilize organic waste from Welch Food's waste stream. "We are clearly excited with the opportunity to demonstrate conclusively that the production of hydrogen is efficient, inexpensive and can meet the increasing demand within the marketplace, both industrial and commercial," stated David McClelland, President of NanoLogix, Inc. About NanoLogix NanoLogix, Inc. www.nanologix.net is a technology application innovator of biogas products and services designed to assist in worldwide energy independence and reduce pollution from renewable, environmentally-friendly energy sources. NanoLogix had also previously engaged in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious human diseases. The Company's patents span the identification and antibiotic sensitivity testing of 34 disease-producing bacteria, including M. tuberculosis (TB), Mycobacterium avium-intracellulare (MAI), pseudomonas, and nocardia. These bacteria are cited as prominent causes of morbidity and mortality in patients with cancer, cystic fibrosis, and AIDS. Additionally, NanoLogix owns a patent for the nontoxic induction of apoptosis in cancer cells utilizing hydrophobic hydrocarbons. Apoptosis is a method for inducing a genetically based induction of "cell suicide" in cells. About Welch's Welch's is the world's leading marketer of Concord and Niagara grape-based products, including grape juice and jelly. The company produces a variety of other fruit-based products, including 100% juices, juice cocktails, and drinks in the following forms: single serve, bottled, refrigerated, and frozen and shelf-stable concentrates. In addition, Welch's produces a number of fruit spread products under both the Welch's and BAMA brand names. Welch's web site can be found at www.welchs.com. This press release contains statements, which may constitute "forward- looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward- statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
SOURCE NanoLogix, Inc.